None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with stable and unstable angina pectoris stabilized on medical therapy, or secondary evaluation of stenosis after acute myocardial infarction 2. Subjects at least 19 years of age 3. Able to provide written informed consent 4. Diameter stenosis 30%-90% by visual estimation 5. Reference vessel size = 2.0 mm in stenosed segment
Exclusion criteria
Exclusion criteria: 1. Subjects with emergent PCI 2. Myocardial infarction within 72 hours 3. Severe asthma or severe chronic obstructive pulmonary disease 4. Allergy to contrast media or adenosine 5. Plasma creatinine 2.0mg/dL or more 6. Atrial fibrillation 7. Heart valve replacement 8. Complex congenital heart disease 9. Severe heart failure (NYHA = III), pulmonary edema, cardiogenic shock 10. Implanted cardiac devices such as pacemakers, implantable cardioverter-defibrillators, or cardiac resynchronization therapy devices 11. Participating in another trial currently or within 30 days 12. Subject belongs to a vulnerable population 13. Pregnant, breast feeding or childbearing potential. 14. Patients unsuitable for enrollment judged by the investigator 15. Prior PCI or CABG with stent in target vessel 16. Aorto-ostial lesion 17. Thrombus containing lesions 18. Poor image quality precluding contour detection 19. Severe tortuosity of target vessel (= 180° curvature observed in two or more consecutive major coronary arteries) 20. Severe overlap over stenosed segments 21. Good contrast filling not possible, myocardial bridging causing poor contour detection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under the ROC Curve | — |
Secondary
| Measure | Time frame |
|---|---|
| Accuracy;Sensitivity;Specificity;Positive Predictive Value;Negative Predictive Value;Correlation Coefficient | — |
Countries
Korea, Republic of
Contacts
Seoul National University Bundang Hospital